Lyons Gary A 的 Form 4 申報
Travere Therapeutics, Inc.（TVTX），2026/8/19 申報
- 申報編號
- 0001123343-26-000010
- 申報時間
- 2026/8/19 16:05 ET
- 交易日
- 2026/8/17-8/18
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 7 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $63.3 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Lyons Gary ACIK 0001123343 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/8/17 | Common Stock | M行使選擇權取得 | +5,000 | $17.44 | +$87,200 | 66,500 | 直接 | |
| 2026/8/17 | Common Stock | S賣出處分 | −1,900 | $62.53F2 | −$118,804.91 | 64,600 | 直接 | |
| 2026/8/17 | Common Stock | S賣出處分 | −2,600 | $63.50F3 | −$165,099.74 | 62,000 | 直接 | |
| 2026/8/17 | Common Stock | S賣出處分 | −500 | $64.16F4 | −$32,081 | 61,500 | 直接 | |
| 2026/8/18 | Common Stock | M行使選擇權取得 | +5,000 | $17.44 | +$87,200 | 66,500 | 直接 | |
| 2026/8/18 | Common Stock | S賣出處分 | −4,100 | $63.27F5 | −$259,390.19 | 62,400 | 直接 | |
| 2026/8/18 | Common Stock | S賣出處分 | −900 | $63.86F6 | −$57,470.13 | 61,500 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/8/17 | Common Stock | M行使選擇權處分 | −5,000 | $0.00 | $0 | 5,000 | 直接 | |
| 2026/8/18 | Common Stock | M行使選擇權處分 | −5,000 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The weighted average sale price for the transaction reported was $62.5289, and the range of prices were between $62.00 and $62.95. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The weighted average sale price for the transaction reported was $63.4999, and the range of prices were between $63.01 and $63.94. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $64.1620, and the range of prices were between $64.04 and $64.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The weighted average sale price for the transaction reported was $63.2659, and the range of prices were between $62.76 and $63.69. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The weighted average sale price for the transaction reported was $63.8557, and the range of prices were between $63.77 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。